MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost
30 million euros to 251.0 million euros, which corresponds to 58.62 euros per
share. EBIT increases to 30.2 million euros.

EQS-News: MPH Health Care AG / Key word(s): Preliminary Results/Annual
Results
MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost
30 million euros to 251.0 million euros, which corresponds to 58.62 euros
per share. EBIT increases to 30.2 million euros.

25.04.2024 / 08:30 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

MPH Health Care AG: Preliminary IFRS result 2023

Equity (net asset value) increases by almost 30 million euros to 251.0
million euros, which corresponds to 58.62 euros per share. EBIT increases to
30.2 million euros. The equity ratio rises to 94.2%.

Berlin, 25 April 2024 - MPH Health Care AG (ISIN: DE000A289V03) announces
the preliminary IFRS consolidated result for the 2023 financial year.
Accordingly, equity increased from EUR 221.4 million to EUR 251.0 million.
The net asset value (NAV) per share rose by 13.3% from EUR 51.72 (31
December 2022) to EUR 58.62 as of
31 December 2023.

In the 2023 financial year, preliminary EBIT totalled EUR 30.2 million
(previous year: EUR 29.6 million) and the IFRS net profit for the year was
EUR 29.5 million (previous year: EUR 29.1 million). As of 31 December 2023,
equity increased by EUR 29.6 million to EUR 251.0 million (previous year:
EUR 221.4 million). The equity ratio rose to 94.2% (previous year: 93.4%)
and remains at a very high level.

MPH AG is an investment company whose investments are recognised as
financial assets under the balance sheet item "Financial assets" and are
measured at fair value through profit or loss as at the balance sheet date.
The net profit for the year is mainly the result of the fair value
measurement of the listed investments held as at the balance sheet date,
resulting from the higher market prices of the investments compared to the
previous year's balance sheet date.

The investments M1 Kliniken AG and CR Energy AG, which are listed on the
Frankfurt Stock Exchange, were operationally successful in 2023.

In the past financial year 2023, M1 Kliniken AG further expanded its market
position in the field of cosmetic medicine and opened four new specialist
medical centres in Germany and abroad. With the opening of the Bucharest and
Sofia locations, the expansion in Eastern Europe, whose target markets are
considered lucrative by the company, will continue. Sales in the "Beauty"
segment rose by 18% to EUR 70.8 million (previous year: EUR 60.2 million).
The EBIT margin in this segment increased from 11.7% in the previous year to
21.9%.

According to the preliminary IFRS figures, the M1 Group's consolidated sales
increased by around 11% to EUR 316.3 million in the 2023 financial year
(previous year: EUR 285.3 million). The M1 Group's 2023 operating profit
(EBIT) increased by 68% to EUR 15.7 million (previous year: EUR 9.3
million). Earnings before taxes in the 2023 financial year totalled EUR 16.4
million (previous year: EUR 10.2 million).

Equity increased by EUR 0.6 million to EUR 143.7 million as of 31 December
2023 (previous year: EUR 143.1 million). The equity ratio decreased slightly
from 72.6% in the previous year to 66.8%. The share price of M1 Kliniken AG
rose by 23.6% from EUR 9.06 on 31 December 2022 to EUR 11.20 on 31 December
2023.

CR Energy AG and its portfolio companies continue to benefit from the high
popularity of their offerings in the markets for sustainable energy supply
concepts, quality and cost-optimised housing and capital investments for
broad sections of the population. According to the preliminary figures for
the 2023 financial year, EBIT of EUR 65 million was achieved (previous year:
EUR 76.3 million). CR Energy's cash and cash equivalents increased
significantly to around EUR 19.5 million as of 31 December 2023 (previous
year: EUR 16.3 million) as a result of the good performance of the
investments. The equity ratio remained high at around 97%. CR Energy is
increasingly involved in the areas of renewable energy supply and
sustainable living, whose markets have a volume in the billions.

The CR Energy AG share price fell from EUR 32.00 on 31 December 2022 to EUR
28.90 on 31 December 2023.

"Despite the ongoing conflict situation in Ukraine and the Middle East and
the persistently high energy costs, we are confident about the development
in 2024. The M1 Group will continue to drive profitable sales growth at its
domestic and foreign locations. The plan is to grow from the current 61
locations to around 80-100 locations by the end of 2025. With its vertically
integrated investment portfolio, CR Energy AG is very well positioned in the
areas of "sustainable energy supply concepts" and "quality and
cost-optimised living space". MPH AG will also be able to systematically
benefit from the positive developments of the investments in the coming
years," says Patrick Brenske, CEO of MPH.

About MPH Health Care AG:

MPH Health Care AG is an investment company with a strategic focus on the
acquisition, development and sale of companies and company shares,
particularly in growth segments of the healthcare market. This includes both
insurance-financed and privately financed segments. However, MPH also
utilises potential outside the healthcare market in high-growth and
profitable sectors.




Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de


---------------------------------------------------------------------------

25.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        MPH Health Care AG
                   Grünauer Straße 5
                   12557 Berlin
                   Germany
   Phone:          030 / 863 21 45 60
   Fax:            030 / 863 21 45 69
   E-mail:         info@mph-ag.de
   Internet:       www.mph-ag.de
   ISIN:           DE000A289V03, DE000A289VT5
   WKN:            A289V0
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt (Basic Board), Munich, Stuttgart, Tradegate
                   Exchange
   EQS News ID:    1888799

End of News EQS News Service
---------------------------------------------------------------------------

1888799 25.04.2024 CET/CEST